Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
122.94
+1.30 (1.07%)
Jul 10, 2026, 3:00 PM CST
SHA:688578 Market Cap
SHA:688578 has a market cap or net worth of 55.32 billion as of July 10, 2026. Its market cap has increased by 28.94% in one year.
Market Cap
55.32B
Enterprise Value
52.17B
Revenue
5.67B
Ranking
n/a
PE Ratio
22.93
Stock Price
122.94
Market Cap Chart
Since December 2, 2020, SHA:688578's market cap has increased from 17.35B to 55.32B, an increase of 218.91%. That is a compound annual growth rate of 22.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 55.32B | 18.04% |
| Dec 31, 2025 | 46.87B | 73.87% |
| Dec 31, 2024 | 26.96B | 43.78% |
| Dec 29, 2023 | 18.75B | 111.69% |
| Dec 30, 2022 | 8.86B | -34.83% |
| Dec 31, 2021 | 13.59B | 6.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 76.90B |
| Asymchem Laboratories (Tianjin) | 57.83B |
| Pharmaron Beijing | 57.18B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 47.32B |
| Suzhou Zelgen Biopharmaceuticals | 38.38B |
| Beijing Wantai Biological Pharmacy Enterprise | 36.34B |
| Shanghai RAAS Blood Products | 30.19B |
| Chongqing Zhifei Biological Products | 29.13B |